Skip to main content
Top

Abdominal Radiology

Issue 1/2018

Special Section: LI-RADS

Content (25 Articles)

Invited article

The LI-RADS adventure—a personal statement

Claude B. Sirlin

Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis

An Tang, Oussama Hallouch, Victoria Chernyak, Aya Kamaya, Claude B. Sirlin

Invited article

Cirrhosis and LI-RADS

Demetrios Papadatos, Kathryn J. Fowler, Ania Z. Kielar, Jennifer Cui, Claude B. Sirlin

US LI-RADS: ultrasound liver imaging reporting and data system for screening and surveillance of hepatocellular carcinoma

Tara A. Morgan, Katherine E. Maturen, Nirvikar Dahiya, Maryellen R. M. Sun, Aya Kamaya

LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound

Avinash R. Kambadakone, Alice Fung, Rajan T. Gupta, Thomas A. Hope, Kathryn J. Fowler, Andrej Lyshchik, Karthik Ganesan, Vahid Yaghmai, Alexander R. Guimaraes, Dushyant V. Sahani, Frank H. Miller

LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents

Cynthia Santillan, Kathryn Fowler, Yuko Kono, Victoria Chernyak

Invited article

LI-RADS® ancillary features on CT and MRI

Victoria Chernyak, An Tang, Milana Flusberg, Demetri Papadatos, Bijan Bijan, Yuko Kono, Cynthia Santillan

LI-RADS categories: concepts, definitions, and criteria

Cynthia Santillan, Victoria Chernyak, Claude Sirlin

Invited article

LI-RADS® algorithm: CT and MRI

Victoria Chernyak, Cynthia S. Santillan, Demetri Papadatos, Claude B. Sirlin

CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI

Stephanie R. Wilson, Andrej Lyshchik, Fabio Piscaglia, David Cosgrove, Hyun-Jung Jang, Claude Sirlin, Christoph F. Dietrich, Tae Kyoung Kim, Juergen K. Willmann, Yuko Kono

Invited article

Management implications and outcomes of LI-RADS-2, -3, -4, and -M category observations

Donald G. Mitchell, Mustafa R. Bashir, Claude B. Sirlin

LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma

Kathryn J. Fowler, Theodora A. Potretzke, Thomas A. Hope, Eduardo A. Costa, Stephanie R. Wilson

Hepatocarcinogenesis and LI-RADS

Kazim H. Narsinh, Jennifer Cui, Demetri Papadatos, Claude B. Sirlin, Cynthia S. Santillan

Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014

Natally Horvat, Ines Nikolovski, Niamh Long, Scott Gerst, Jian Zheng, Linda Ma Pak, Amber Simpson, Junting Zheng, Marinela Capanu, William R. Jarnagin, Lorenzo Mannelli, Richard Kinh Gian Do

Implementation of LI-RADS into a radiological practice

Stefan T. Siedlikowski, Ania Z. Kielar, Eleanor L. Ormsby, Bijan Bijan, Christopher Kagay

Invited article

Liver transplantation for hepatocellular carcinoma

Jennifer Berumen, Alan Hemming

Invited article

LI-RADS and transplantation for hepatocellular carcinoma

An Tang, Kathryn J. Fowler, Victoria Chernyak, William C. Chapman, Claude B. Sirlin

Liver-directed therapy for hepatocellular carcinoma

Kazim H. Narsinh, David P. Duncan, Isabel G. Newton, Jeet Minocha, Steven C. Rose

Invited article

Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm

Ania Kielar, Kathryn J. Fowler, Sara Lewis, Vahid Yaghmai, Frank H. Miller, Hooman Yarmohammadi, Charles Kim, Victoria Chernyak, Takeshi Yokoo, Jeffrey Meyer, Isabel Newton, Richard K. Do

Review Paper

LI-RADS: a glimpse into the future

Claude B. Sirlin, Ania Z. Kielar, An Tang, Mustafa R Bashir

Letter to the Editor

Letter to the editor

Yeun-Yoon Kim, Chansik An, Myeong-Jin Kim

Invited article

Letter to the editor response

Kathryn J. Fowler, Theodora A. Potretzke, Thomas A. Hope, Eduardo A. Costa, Stephanie R. Wilson, Claude B. Sirlin, An Tang, Ania Kielar

Author Correction

Correction to: LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound

Avinash R. Kambadakone, Alice Fung, Rajan T. Gupta, Thomas A. Hope, Kathryn J. Fowler, Andrej Lyshchik, Karthik Ganesan, Vahid Yaghmai, Alexander R. Guimaraes, Dushyant V. Sahani, Frank H. Miller

Author Correction

Correction to: Letter to the editor

Yeun-Yoon Kim, Chansik An, Myeong-Jin Kim

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.